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Although it is usually believed that 3D methods 
offer a clear advantage over the traditional Hansch 
approach, the latter seems to keep safe. The results of 
classical 3D QSAR techniques, in particular COMFA, 
are very sensitive even to a minute changes in the 
alignment of molecules, which both complicate any 
study and bring a problem of chance correlation. On 
the other hand, standard 3D descriptors performed less 
successful than 2D fingerprints. These facts clearly 
indicate that new concepts and computational tools are 
still needed. One of the alternatives of the potential use 
in this field are neural networks, and particularly 
self-organizing neural networks, which can be applied 
to design much more flexible techniques.
The aim of the current work is to discuss the 
results of the study aimed at the implementation of the 
coupled neural network (self-organizing Kohonen 
map) and PLS system for analyzing the similarity of 
three dimensional molecular surfaces, modeling 3D 
QSARs and predicting molecular properties.
EXPERIMENTAL
All the data are extracted from the literature 
(1-5). For modeling purposes we used CORINA, 
PETRA, MATCH 3D, SURFACE and KMAP pro­
grams run on SGI workstation. Alternatively, we used 
MATLAB environment for programming the neuronal 




A comparison of the Kohonen maps of the elect­
rostatic potential can be used to illustrate and interprete 
the differences between molecules. It has been demon­
strated before that even if we cannot explain molecular 
effects, the style of the maps often correlates with 
biological activity of the molecules. Although the 
method proved its usefulness, there are some comp­
lications. The dependence of the final pattern upon 
many parameters controlling the performance of neural 
network, and consequently the dependence upon the 
software used for simulation, seems to be one of the 
most important. In order to illustrate this problem we 
will use here an example of the organic peroxides of 
antimalarial activity. The Kohonen maps of these 
compounds were simulated by Jefford et al. and repor­
ted in Ref. (7). In Figure la to If we used different 
color scales (A, B) in order to obtain maximal similari­
ty to the original maps (7), but, in fact, we failed to find 
satisfactory similarity.
In contrast, we have observed that the use of the 
so called comparative Kohonen mapping can provide 
highly reproducible results. Recently, we have desig­
ned the COMSA method capable of quantitative mo­
delling of 3D QSARs. Table 1 compares the COMSA 
and COMFA models obtained for several series of 
bioactivc compounds. The COMSA results are always 
at least slightly better than the COMFA ones.
Despite many efforts, SAR data cannot always be 
modeled to take the form of the quantitative QSAR. In 
such cases a comparative method can also be used for 
visualizing SAR data. We have shown recently that it 





Figure 1. The Kohonen maps of some organic peroxides of an­
ti malarial activity.
.styrylquinolines - new inhibitors of HIV integrase (8). 
This method not only gave us a clear hint explaining 
the most important molecular feature controlling the 
activity of the series of novel HIV inhibitors, but also 
was predictive enough to give a proper guess for the 
activity of a set of newly synthesized compounds.
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Table 1. A comparison of the COMSA and COMFA models obtained for several bioactive series.
The data were taken from: 11 Ref. [4], b Ref. [6], 1 Ref. [2], *' Ref [1], c Ref [3], 1 Ref. [5],
Model Compounds Type of activity COMSA
q2 (no. of components)
COMFA
q2 (no. of components)
1 Benzoic acids" pK« 0.90 (5) 0.75 (5)
2 Alkanoic acids" pKa 0.86 (5) 0.52 (5)
3 HEPT-inhibitors HIV-1 (RT)h log(l/C) 0.79 (4) 0.73 (7)
4 Anthraquinone vat dyes1 affinity 0.88 (7) 0.84 (5)
5 Sulfinoquinolines11 log(LDso) 0.89 (8) 0.70 (6)
6 Steroids" affinity 0.77 (5) 0.72 (5)
7 CBG' affinity 0.88 (1) 0.73 (4)
8 TBG1 affinity 0.76 (5) 0.76 (8)
9 Benzoic acids' Hammett constant 0.91 (4) 0.92 (8)
Using this technique we designed new synthetic targets 
which we are now synthesizing in our laboratory.
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